Literature DB >> 8665836

Melting profile and temperature dependent binding constant of an anticancer drug daunomycin-DNA complex.

Y Z Chen1, E W Prohofsky.   

Abstract

We calculate thermal fluctuational base pair opening probability and the drug binding constant of a daunomycin-bound Poly d(CGTA).Poly d(TACG) at temperatures from room temperature to its melting temperature. For comparison we also carry out a calculation on a drug-free DNA with the same sequence. Our calculations are carried out by means of a statistical approach using microscopic structures and established force fields and with cooperative effects incorporated into the algorithm. Both hydrogen bond disruption probabilities and drug unstacking probability are determined self-consistently. These probabilities are then used to determine temperature dependent base pair opening probabilities and the drug binding constant. The calculated base pair opening probabilities and drug binding constant are found to be in fair agreement with experiments carried out at room temperature. Our calculation shows cooperative base pair disruption and drug dissociation at certain critical temperatures close to the observed melting temperatures for similar helices. We find that the temperature dependence of the drug binding constant fits well to the van't Hoff relation, in agreement with observations. Our calculation indicates the occurrence of a premelting transition in the drug-bound DNA helix. Some comments are made about this premelting transition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665836     DOI: 10.1007/bf00205101

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  29 in total

1.  The role of a minor groove spine of hydration in stabilizing poly(dA).poly(dT) against fluctuational interbase H-bond disruption in the premelting temperature regime.

Authors:  Y Z Chen; E W Prohofsky
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

2.  Theoretical calculations of the helix-coil transition of DNA in the presence of large, cooperatively binding ligands.

Authors:  J D McGhee
Journal:  Biopolymers       Date:  1976-07       Impact factor: 2.505

3.  Electrostatic forces at helix-coil boundaries in DNA.

Authors:  R D Blake; S G Delcourt
Journal:  Biopolymers       Date:  1990-02-05       Impact factor: 2.505

4.  Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments.

Authors:  J B Chaires; J E Herrera; M J Waring
Journal:  Biochemistry       Date:  1990-07-03       Impact factor: 3.162

5.  The interaction of daunomycin with polydeoxynucleotides.

Authors:  D R Phillips; A DiMarco; F Zunino
Journal:  Eur J Biochem       Date:  1978-04-17

6.  Equilibrium studies on the interaction of daunomycin with deoxypolynucleotides.

Authors:  J B Chaires
Journal:  Biochemistry       Date:  1983-08-30       Impact factor: 3.162

7.  Premelting base pair opening probability and drug binding constant of a daunomycin-poly d(GCAT).poly d(ATGC) complex.

Authors:  Y Z Chen; E W Prohofsky
Journal:  Biophys J       Date:  1994-03       Impact factor: 4.033

8.  Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

Authors:  G J Quigley; A H Wang; G Ughetto; G van der Marel; J H van Boom; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  A theoretical investigation on the sequence selective binding of daunomycin to double-stranded polynucleotides.

Authors:  K X Chen; N Gresh; B Pullman
Journal:  J Biomol Struct Dyn       Date:  1985-12

10.  DNA-drug interactions. The crystal structures of d(TGTACA) and d(TGATCA) complexed with daunomycin.

Authors:  C M Nunn; L Van Meervelt; S D Zhang; M H Moore; O Kennard
Journal:  J Mol Biol       Date:  1991-11-20       Impact factor: 5.469

View more
  1 in total

1.  Classification of DNA sequences based on thermal melting profiles.

Authors:  Edward Reese; Vishwanathan V Krishnan
Journal:  Bioinformation       Date:  2010-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.